Severity of Nonalcoholic Fatty Liver Disease is Associated with Development of Metabolic Syndrome: Results of a 5-Year Cohort Study
Journal Title: International Journal of Diabetology & Vascular Disease Research (IJDVR) - Year 2015, Vol 3, Issue 8
Abstract
Aims: Nonalcoholic fatty liver disease (NAFLD) is considered to be a hepatic manifestation of metabolic syndrome (MS). However, a few studies have examined the effect of NAFLD on the development of MS. We evaluated the relationship between the development of MS and clinical severity of NAFLD according to alanine aminotransferase (ALT) levels. Methods: A retrospective cohort study was conducted. Participants who underwent abdominal ultrasonography and blood samplings for health check-ups both in 2005 and 2010 were recruited. NAFLD was diagnosed if a person showed fatty liver on ultrasonography without significant alcohol consumption. Subjects with MS at baseline were excluded. Results: A total of 2,728 subjects met the inclusion criteria. Fatty liver (FL) with normal ALT was found in 369 (13.5%) subjects and FL with elevated ALT in 328 (12.0%). During 5 years of follow up, 582 (21.3%) incident cases of MS developed between 2005 and 2010. The incidence of MS was higher in patients with NAFLD compared to control group (41.2% in FL with elevated ALT, 34.7% in FL with normal ALT and 15.7% in control, p<0.001). Multivariate analysis showed that odds ratio (OR) and 95% confidence interval (CI) for MS increased according to the severity of NAFLD [OR (95% CI), 1.29 (0.97−1.71) in FL with normal ALT and 1.54 (1.18−1.33) in FL with elevated ALT, p=0.01]. Conclusions: We have demonstrated that development of MS is significantly increased according to the clinical severity of NAFLD. These findings have implications in the clinical availability of NAFLD as a predictor of MS.
Authors and Affiliations
Jeong Yoon Yim
Keywords
Related Articles
- EP ID EP198991
- DOI 10.19070/2328-353X-1500025
- Views 72
- Downloads 0
A Non-Invasive Glucose Estimation in Saliva Samples by using Pre Column Derivatised RP-HPLC
Diagnostic devices available in the market to measure blood glucose level which requires blood as diagnostic body fluid. Hence, necessity arises to find some non-invasive diagnostic mean to measure body glucose level fre...
What Should the Hemoglobin A1c Level Goal be in Diabetics?
An increased hemoglobin A1c level in patients with diabetes mellitus is associated with an increased incidence of ischemic stroke, increased severity of coronary artery disease, and an increased severity of peripheral ar...
Eating Timing and Diabetes
Eating Timing and Diabetes
Pathophysiologic Aspects of Hypertension
Hypertension is defined as a sustained increase in blood pressure. Historically, the level of blood pressure designating hypertension has been a systolic blood pressure of 140 mm Hg or more and/or a diastolic blood press...
Sex-based Association of CYP11B2 (-344 C/T) Polymorphism in Indian Type 2 Diabetic Patients.
Background: CYP11B2 gene association studies have been conducted on hypertension, T2DM, and T2DNH in subjects from Caucasian, Asian, and Indian populations. The -344 C/T variant is a commonly reported polymorphism of the...